Skip to main content
. Author manuscript; available in PMC: 2012 Jul 30.
Published in final edited form as: Am J Geriatr Psychiatry. 2009 Jun;17(6):473–482. doi: 10.1097/jgp.0b013e31819b87b2

TABLE 2.

Functional Limitations and Healthcare Utilization in Healthy and Anxious Older Adults

M (SD)
Ha Effect Sizeb Healthy Versus GAD Without Comorbidity Effect Sizeb Healthy Versus GAD Plus Comorbidity
Healthy Comparisons (n = 42) GAD Without Comorbidity (n = 81) GAD Plus Comorbidity (n = 83)
LLFDI
 Activity limitation 73.7 (6.9) 62.4 (12.4) 60.4 (12.8) 38.1 0.21 0.17
 Participation restriction (frequency) 62.9 (6.4) 57.4 (8.3) 55.9 (9.2) 19.5 0.30 0.26
MOS SF-36
 General health 80.5 (13.3) 58.8 (18.5) 57.7 (21.6) 41.2 0.18 0.17
 Physical functioning 78.6 (18.5) 59.4 (27.0) 61.3 (26.8) 16.2 0.31 0.30
 Mental health 91.7 (5.5) 59.3 (15.2) 55.6 (16.6) 94.7 0.02 0.01
 Vitality 72.3 (14.5) 46.2 (17.8) 40.2 (20.5) 62.9 0.10 0.12
 Bodily pain 74.5 (19.7) 55.4 (22.3) 56.0 (25.0) 21.7 0.28 0.25
 Social functioning 97.6 (6.3) 69.0 (22.1) 66.0 (25.0) 59.7 0.11 0.13
 Role limitations—physical health 86.3 (21.5) 46.3 (40.7) 45.4 (40.5) 33.2 0.22 0.22
 Role limitations—emotional health 95.2 (15.7) 45.7 (38.2) 46.7 (39.5) 51.3 0.16 0.15
Health service utilization (no. of visits, past 6 months) 3.3 (2.4) 6.7 (7.8) 6.3 (9.4) 7.9 0.34 0.36

Note: GAD: Generalized anxiety disorder; LLFDI: Late Life Function and Disability Instrument; MOS SF-36: Medical Outcomes Study 36-Item Short Form Survey Instrument.

a

Degrees of freedom for Kruskal-Wallis H statistic = 2; all p values <0.001 except Health Service Utilization (p = 0.02).

b

Values closer to 0 indicate larger effect sizes with GAD group having poorer scores; 0.50 indicates no difference between groups.